HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 278263Generated: October 30, 2026
tert-Butyl 4-oxopiperidine-1-carboxylate → HCID 21912813, compound
https://huagongshe.com/reaction/278263
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | tert-Butyl 4-oxopiperidine-1-carboxylate | HCID 735900 | — |
| Reactant | HCID 21912705 | HCID 21912705 | — |
| Reactant | HCID 178418306 | HCID 178418306 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 21912813 | HCID 21912813 | 22.5% |
Reaction Steps
To a solution of 2-ethyl-3-bromoindazole (3.4 g, 15.18 mmol) in THF (30 mL) was added t-BuLi (1.7 M in pentane, 10.72 mL, 18.22 mmol) dropwise at −78° C. After stirring at −78° C. for 20 min., was added tert-butyl 4-oxo-1-piperidinecarboxylate (3.03 g, 15.18 mmol) in THF (10 mL) dropwise at −78° C. The mixture was stirred at −78° C. for 10 min. and at rt for 18 h. After the reaction was quenched with aq. NH4Cl, the mixture was partitioned between ethyl acetate and water. The aqueous layer was extracted with ethyl acetate (3×). The combined organic phases were washed with brine, and dried over anhydrous magnesium sulfate. Concentration followed by purification by flash chromatography (hexanes ethyl acetate=4:1, then 1:1) to give 1.18 g of the title compound as a foamy solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06358979B1 |
|---|
| Source dataset | uspto-grants-2002_03 |
|---|
| ORD ID | ord-c9d0f6ec84804ac9b064301d98ccf8b8 |
|---|
| Source note | uspto-grants-2002_03 |
|---|